Heron Therapeutics Inc (HRTX)

Apr 12, 2026

Total debt per share of Heron Therapeutics Inc – LSE:0J4V - TradingView — Track All Markets

Apr 12, 2026

Apr 11, 2026

Pullback Watch: Can Heron Therapeutics Inc expand into new markets2026 Sector Moves & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Apr 11, 2026

Apr 06, 2026

Heron Therapeutics (HRTX) CEO exercises 62,500 RSUs into common stock - Stock Titan

Apr 06, 2026

Apr 06, 2026

Earnings Miss: How does Heron Therapeutics Inc compare to its peersQuarterly Trade Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Heron Therapeutics Executive Employment Agreements: Key Terms, Termination, and Restrictive Covenants Explained - Minichart

Apr 06, 2026

Apr 06, 2026

Heron Therapeutics Strengthens Executive Contracts Amid Strategic Focus - TipRanks

Apr 06, 2026

Apr 06, 2026

Heron Therapeutics (NASDAQ: HRTX) revises executive severance and CIC - Stock Titan

Apr 06, 2026

Apr 03, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Analysts - marketbeat.com

Apr 03, 2026

Apr 03, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of “Hold” by Analysts - Defense World

Apr 03, 2026

Apr 01, 2026

HRTX Stock Price, Quote & Chart | HERON THERAPEUTICS INC (NASDAQ:HRTX) - ChartMill

Apr 01, 2026

Mar 30, 2026

Q1 Earnings Forecast for HRTX Issued By Northland Securities - MarketBeat

Mar 30, 2026

Mar 28, 2026

Moving Averages: How does Heron Therapeutics Inc compare to its peersWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

Wall Street Recap: How does Heron Therapeutics Inc compare to its peersTrade Entry Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Vanguard realigns holdings; Heron Therapeutics (HRTX) ownership shown as 0 - Stock Titan

Mar 27, 2026

Mar 27, 2026

What is Northland Securities' Estimate for HRTX Q3 Earnings? - MarketBeat

Mar 27, 2026

Mar 24, 2026

If You Invested $1,000 in Heron Therapeutics Inc (HRTX) - Stock Titan

Mar 24, 2026

Mar 16, 2026

Market Trends: Is Heron Therapeutics Inc stock technically oversold2026 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 16, 2026

Mar 15, 2026

Clearline Capital LP Increases Holdings in Heron Therapeutics, Inc. $HRTX - MarketBeat

Mar 15, 2026

Mar 15, 2026

Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Mar 15, 2026

Mar 09, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Mar 09, 2026

Mar 08, 2026

HRTX SEC FilingsHeron Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 08, 2026

Mar 06, 2026

Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Mar 06, 2026

Mar 05, 2026

Heron Therapeutics Signals Profitable Growth After Strong Quarter - TipRanks

Mar 05, 2026

Mar 05, 2026

Earnings Call Summary | Heron Therapeutics(HRTX.US) Q4 2025 Earnings Conference - 富途牛牛

Mar 05, 2026

Mar 02, 2026

HC Wainwright Has Negative Forecast for HRTX FY2026 Earnings - MarketBeat

Mar 02, 2026

Mar 02, 2026

What is Northland Securities' Forecast for HRTX Q1 Earnings? - MarketBeat

Mar 02, 2026

Feb 28, 2026

Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to Strong Sell at Zacks Research - MarketBeat

Feb 28, 2026

Feb 28, 2026

HRTX Should I Buy - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026

Feb 27, 2026

What is HC Wainwright's Estimate for HRTX Q1 Earnings? - MarketBeat

Feb 27, 2026

Feb 26, 2026

HRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Feb 26, 2026

Feb 26, 2026

Heron (HRTX) Q4 2025 Earnings Call Transcript - AOL.com

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics: Profitable Growth Outlook and Acute Care Momentum Underpin Buy Rating and $3 Target - TipRanks

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment - MSN

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HRTX) 2026-02-26 - Seeking Alpha

Feb 26, 2026

Feb 26, 2026

Key facts: Heron Therapeutics projects $173-$183M revenue by 2026; ZYNRELEF adoption rises; credit facilities expanded - TradingView

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Earnings call transcript: Heron Therapeutics Q4 2025 reports strong growth By Investing.com - Investing.com Canada

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Feb 26, 2026

Feb 26, 2026

HRTX: 2025 net revenue rose 7.4% to $154.9M, with strong Acute Care growth and positive EBITDA - TradingView

Feb 26, 2026

Feb 26, 2026

HERON THERAPEUTICS ($HRTX) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics: Q4 Earnings Snapshot - Citizen Tribune

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics: Fourth Quarter Earnings Overview - Bitget

Feb 26, 2026

Feb 26, 2026

HERON THERAPEUTICS, INC. /DE/ SEC 10-K Report - TradingView

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics Q4 revenue dips as Acute Care segment holds fort - TradingView

Feb 26, 2026

Feb 26, 2026

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results - The Manila Times

Feb 26, 2026

Feb 26, 2026

HRTX: 2025 net revenue rose 7.4% to $154.9M, driven by Acute Care growth and new CMS J-Codes - TradingView

Feb 26, 2026